BHC: מכפיל מחיר להכנסות Bausch Health Companies Inc.

The P/S multiple reflects the financial pressure on Bausch Health Companies (BHC), as massive debts absorb nearly all free capital, a fact confirmed by the current 0.30 metric. The holding company relies on established ophthalmology and gastroenterology brands that serve as steady cash generators. While the company maintains partial pricing power over its patents, it faces fierce market competition within the generics segment.

For high-quality stock selection, it is essential for an investor to determine the fair value of a business relative to its actual cash flows. The P/S multiple compares the market capitalization of Bausch Health Companies (BHC) to its annual revenue, enabling an assessment of the monetization efficiency of its diversified portfolio of ophthalmology and cosmetic products, while analyzing P/S volatility to eliminate the risk of overpaying for the asset at its peak valuation.